No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
J.P. Morgan's Top Healthcare Stocks for 2025
Xenon Pharmaceuticals (XENE) Up 2.4% Since Last Earnings Report: Can It Continue?
H.C. Wainwright Maintains Xenon Pharmaceuticals(XENE.US) With Buy Rating, Maintains Target Price $53
Xenon Pharmaceuticals Analyst Ratings
Promising Efficacy and Tolerability: Douglas Tsao's Buy Rating on Xenon Pharmaceuticals' Azetukalner
Xenon Pharmaceuticals Reveals Promising Epilepsy Drug Data